Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FREQ

Frequency Therapeutics (FREQ) Stock Price, News & Analysis

Frequency Therapeutics logo

About Frequency Therapeutics Stock (NASDAQ:FREQ)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$0.28
$0.32
50-Day Range
$0.22
$14.98
52-Week Range
$0.18
$16.00
Volume
309,164 shs
Average Volume
822,537 shs
Market Capitalization
$10.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIb clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, and The Scripps Research Institute. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.

Remove Ads
Receive FREQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Frequency Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FREQ Stock News Headlines

Trevi Therapeutics RIVER trial meets primary endpoint
Trevi Therapeutics RIVER trial meets primary endpoint
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
Silence Therapeutics Advances Promising siRNA Therapy for PV
See More Headlines

FREQ Stock Analysis - Frequently Asked Questions

Frequency Therapeutics, Inc. (NASDAQ:FREQ) announced its quarterly earnings data on Monday, November, 15th. The company reported ($0.73) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.57) by $0.16.

Frequency Therapeutics (FREQ) raised $102 million in an IPO on Thursday, October 3rd 2019. The company issued 6,700,000 shares at a price of $14.50-$16.00 per share. J.P. Morgan, Goldman Sachs and Cowen served as the underwriters for the IPO and Mizuho Securities was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Frequency Therapeutics investors own include Tesla (TSLA), ImmunoGen (IMGN), Advanced Micro Devices (AMD), AMC Entertainment (AMC), Ovintiv (OVV), Plug Power (PLUG) and TherapeuticsMD (TXMD).

Company Calendar

Last Earnings
11/15/2021
Today
4/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FREQ
Fax
N/A
Employees
46
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-81,580,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$14.07 million
Price / Cash Flow
N/A
Book Value
$1.96 per share
Price / Book
0.15

Miscellaneous

Free Float
30,385,000
Market Cap
$10.94 million
Optionable
Not Optionable
Beta
0.84
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:FREQ) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners